These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21975810)

  • 1. Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides.
    Hu K; Zhu L; Liang H; Hu F; Feng J
    Arch Pharm Res; 2011 Sep; 34(9):1487-94. PubMed ID: 21975810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bufadienolide-loaded submicron emulsion for oral administration: stability, antitumor efficacy and toxicity.
    Li W; Lin X; Yang Z; Zhang W; Ren T; Qu F; Wang Y; Zhang N; Tang X
    Int J Pharm; 2015 Feb; 479(1):52-62. PubMed ID: 25545797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation.
    Tian JL; Ke X; Chen Z; Wang CJ; Zhang Y; Zhong TC
    Pharmazie; 2011 May; 66(5):362-7. PubMed ID: 21699070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Weng Y; Wang L; He H; Yang J; Tang X
    Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method to load topotecan into liposomes driven by a transmembrane NH₄EDTA gradient.
    Yang Y; Ma Y; Wang S
    Eur J Pharm Biopharm; 2012 Feb; 80(2):332-9. PubMed ID: 22041601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
    Vaidya B; Vyas SP
    J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of total bufadienolides from toad venom against H22 tumor in mice and their metabolites].
    Li Z; Gao H; Wang J; Qu T; Chen L; Wang Z; Zhang Q
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):2987-93. PubMed ID: 22308689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of long-circulating nolatrexed dihydrochloride liposomes and its antitumor activity].
    Chen SZ; Wang SM; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):403-5. PubMed ID: 18359701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan.
    Hao YL; Deng YJ; Chen Y; Wang KZ; Hao AJ; Zhang Y
    J Pharm Pharmacol; 2005 Oct; 57(10):1279-87. PubMed ID: 16259756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles.
    Fu JY; Blatchford DR; Tetley L; Dufès C
    J Control Release; 2009 Dec; 140(2):95-9. PubMed ID: 19709637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
    Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
    Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
    Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.
    Drummond DC; Marx C; Guo Z; Scott G; Noble C; Wang D; Pallavicini M; Kirpotin DB; Benz CC
    Clin Cancer Res; 2005 May; 11(9):3392-401. PubMed ID: 15867240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
    J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
    Lu JL; Wang JC; Zhao SX; Liu XY; Zhao H; Zhang X; Zhou SF; Zhang Q
    Eur J Pharm Biopharm; 2008 Aug; 69(3):899-907. PubMed ID: 18434109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice.
    Chang M; Wu M; Li H
    Drug Deliv; 2018 Nov; 25(1):1984-1995. PubMed ID: 30499350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.